Quantcast
Home > Quotes > VBLT

Vascular Biogenics Ltd. Ordinary Shares (VBLT) Quote & Summary Data

VBLT 
$1.12
*  
0.02
1.82%
Get VBLT Alerts
*Delayed - data as of Nov. 19, 2018  -  Find a broker to begin trading VBLT now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    VBLT Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
Today's High / Low
$ 1.18 / $ 1.10
Share Volume
106,109
50 Day Avg. Daily Volume
145,049
Previous Close
$ 1.10
52 Week High / Low
$ 8.75 / $ 1.10
Market Cap
40,158,116
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
106,109
50 Day Avg. Daily Volume:
145,049

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.37

Trading Range

The current last sale of $1.12 is 1.82% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 1.18 $ 8.75
 Low: $ 1.10 $ 1.10

Company Description (as filed with the SEC)

The legal name of our company is Vascular Biogenics Ltd. and we conduct business under the name VBL Therapeutics. We were incorporated in Israel on January 27, 2000 as a company limited by shares under the name Medicard Ltd. In January 2003, we changed our name to Vascular Biogenics Ltd. Our registered and principal office is located 8 HaSatat St., Modi'in, Israel 7178106. Our service agent in the United States is located at c/o CT Corporation System, 111 8th Avenue, New York, New York 10011 and our telephone number is 972-8-9935000. Throughout this prospectus, we refer to various trademarks, service marks and trade names that we use in our business. The "Vascular Biogenics" design logo, "VBL Therapeutics," "Vascular Targeting System," "VTS," "Lecinoxoids," "VB-111," "VB-201," the "GLOBE" design logo and other trademarks or service marks of Vascular Biogenics Ltd. appearing in this prospectus are the property of Vascular Biogenics Ltd.  ... More ...  


Risk Grade

Where does VBLT fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 1.10
Open Date:
Nov. 19, 2018
Close Price:
$ 1.12
Close Date:
Nov. 19, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x